{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:08:34Z","timestamp":1792098514270,"version":"4.4.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009975","name":"Charotar University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.clinre.2022.102003","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T23:46:08Z","timestamp":1660175168000},"page":"102003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["NAFLD: genetics and its clinical implications"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-6470","authenticated-orcid":false,"given":"Dixa","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-3773","authenticated-orcid":false,"given":"Palash","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2022.102003_bib0001","series-title":"Nonalcoholic Fatty Liver Disease-An Update","article-title":"The rise in the prevalence of nonalcoholic fatty liver disease and hepatocellular carcinoma","author":"Sherif","year":"2019"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clinre.2019.10.001","article-title":"Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?","volume":"44","author":"Cordeiro","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.clinre.2022.102003_bib0004","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1071","article-title":"Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease","volume":"33","author":"Lohmueller","year":"2003","journal-title":"Nat Genet"},{"issue":"7571","key":"10.1016\/j.clinre.2022.102003_bib0008","first-page":"68","article-title":"1000 genomes project consortium. A global reference for human genetic variation","volume":"526","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2022.102003_bib0009","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A rference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.clinre.2022.102003_bib0010","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/ijerph16152755","article-title":"Novel insights into the genetic landscape of nonalcoholic fatty liver disease","volume":"16","author":"Taliento","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clinre.2022.102003_bib0011","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2022.102003_bib0012","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12072-015-9689-y","article-title":"Genetic and epigenetic mechanisms of NASH","volume":"10","author":"Eslam","year":"2016","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101769","article-title":"Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease","volume":"46","author":"Boursier","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2022.102003_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2022.102003_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2016.05.013","article-title":"Contrasting the genetic architecture of 30 complex traits from summary association data","volume":"99","author":"Shi","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinre.2022.102003_bib0016","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.102003_bib0017","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI93465","article-title":"Nonal- coholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis","volume":"127","author":"Caussy","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2022.102003_bib0018","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotrans- ferase activity independent of obesity and alcohol: a study in mono- zygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.102003_bib0019","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholicfatty liver disease\u2014meta-analyticassessment of prevalence, incidence,and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2022.102003_bib0021","doi-asserted-by":"crossref","unstructured":"Nischalke H.D., Berger C., Luda C., et al. The PNPLA3 rs738409 148M\/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis. https:\/\/doi.org\/10.1371\/journal.pone.0027087","DOI":"10.1371\/journal.pone.0027087"},{"key":"10.1016\/j.clinre.2022.102003_bib0022","doi-asserted-by":"crossref","unstructured":"Hrubec Z., Ornenn GS. Evidence of Genetic Predisposition to Alcoholic Cirrhosis and Psychosis: Twin Concordances for Alcoholism and Its Biological End Points by Zygosity among Male Veterans; 1981. https:\/\/doi.org\/10.1111\/j.1530-0277.1981.tb04890.x.","DOI":"10.1111\/j.1530-0277.1981.tb04890.x"},{"issue":"3","key":"10.1016\/j.clinre.2022.102003_bib0023","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/jhep.2003.50127","article-title":"Genetic polymorphism and the progression of liver fibrosis: Acritical appraisal","volume":"37","author":"Bataller","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0024","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"S","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3945\/ajcn.114.095125","article-title":"Isoleucine-to-methionine substitution at residue148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes","volume":"101","author":"Bo","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"42","key":"10.1016\/j.clinre.2022.102003_bib0026","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.3748\/wjg.v18.i42.6018","article-title":"PNPLA3, the triacylglycerol synthesis\/hydrolysis\/storage dilemma, and nonalcoholic fatty liver disease","volume":"18","author":"Sookoian","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0027","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2022.102003_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/boc.201200036","article-title":"PNPLA3\/adiponutrin functions in lipiddroplet formation","volume":"105","author":"Chamoun","year":"2013","journal-title":"Biol Cell"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0029","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbrc.2014.03.078","article-title":"Adiponutrin: a multimeric plasma protein","volume":"446","author":"Winberg","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0030","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2022.102003_bib0031","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s42255-019-0066-3","article-title":"Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes","volume":"1","author":"Yang","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.clinre.2022.102003_bib0032","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127902","article-title":"Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids","volume":"4","author":"Luukkonen","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinre.2022.102003_bib0033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-230X-12-111","article-title":"The i148m polymorphism influences serum adiponectin in patients with fatty liver and healthy controls","volume":"12","author":"Valenti","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0034","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.clinre.2016.05.004","article-title":"Screening for rare variants in the PNPLA3 gene in obese liver biopsy patients","volume":"40","author":"Zegers","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2022.102003_bib0035","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"Donati","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2022.102003_bib0036","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2022.102003_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102658","article-title":"Mboat7 down-regulation by hyper- insulinemia induces fat accumulation in hepatocytes","volume":"52","author":"Meroni","year":"2020","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.clinre.2022.102003_bib0038","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1194\/jlr.P076034","article-title":"Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns","volume":"58","author":"Kim","year":"2017","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.clinre.2022.102003_bib0039","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.clinre.2019.01.008","article-title":"Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility","volume":"43","author":"Xia","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2019.03.026","article-title":"Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations","volume":"71","author":"L","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.102003_bib0041","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0042","article-title":"Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"9","author":"SP","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinre.2022.102003_bib0043","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterationsin adults with alpha-1-antitrypsin deficiency caused by the Pi*ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0044","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.clinre.2016.05.004","article-title":"Screening for rare variants in the PNPLA3 gene in obese liver biopsy patients","volume":"40","author":"Zegers","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis","volume":"31","author":"BC","year":"2020","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.clinre.2022.102003_bib0046","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparision of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Su","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.clinre.2022.102003_bib0047","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0048","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0049","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.clinre.2019.04.005","article-title":"Non-alcoholic fatty liver disease in non-obese individuals: prevalence, pathogenesis and treatment","volume":"43","author":"Molina-Molina","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2022.102003_bib0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2004.01.028","article-title":"Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis","volume":"40","author":"Namikawa","year":"2004","journal-title":"J Hepatol"},{"issue":"21","key":"10.1016\/j.clinre.2022.102003_bib0051","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activityin liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.clinre.2022.102003_bib0052","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.clinre.2016.05.001","article-title":"Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma","volume":"40","author":"Lyu","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7571","key":"10.1016\/j.clinre.2022.102003_bib0053","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0054","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinre.2022.102003_bib0055","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genomewide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5576","key":"10.1016\/j.clinre.2022.102003_bib0056","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"SB","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008629","article-title":"A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease","volume":"16","author":"Emdin","year":"2020","journal-title":"PLOS Genet"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0058","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/liv.14321","article-title":"Genetic variants that associate with cirrhosis have pleiotropic effects on human traits","volume":"40","author":"Chen","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2022.102003_bib0059","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2022.102003_bib0060","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMc1804027","article-title":"HSD17B13 and chronic liver disease in blacks and Hispanics","volume":"379","author":"Kozlitina","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clinre.2022.102003_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000540","article-title":"Prediction and interaction in complex disease genetics: experience in Type 1 diabetes","volume":"5","author":"Clayton","year":"2009","journal-title":"PLOS Genet"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0062","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrg.2017.101","article-title":"Genetic architecture: the shape of the genetic contribution to human traits and disease","volume":"19","author":"NJ","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.clinre.2022.102003_bib0063","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analysis of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across emerge network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0064","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.25011\/cim.v35i4.17153","article-title":"PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population","volume":"35","author":"Li","year":"2012","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.clinre.2022.102003_bib0065","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.bbadis.2018.05.003","article-title":"The role of xanthine oxidoreductase and uric acid in metabolic syndrome","volume":"1864","author":"Battelli","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.clinre.2022.102003_bib0066","first-page":"59","article-title":"Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC","volume":"6263","author":"Gandhy","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinre.2022.102003_bib0067","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3109\/00365521.2012.725093","article-title":"Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease","volume":"47","author":"Yilmaz","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2022.102003_bib0068","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41390-019-0303-1","article-title":"Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity","volume":"85","author":"Di Costanzo","year":"2019","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clinre.2022.102003_bib0069","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2016.05.020","article-title":"Childhood predictors of adult fatty liver. The cardiovascular risk in young finns study","volume":"65","author":"Suomela","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.102003_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1194\/jlr.P067454","article-title":"Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study","volume":"58","author":"Krawczyk","year":"2017","journal-title":"J Lipid Res"},{"issue":"43","key":"10.1016\/j.clinre.2022.102003_bib0071","doi-asserted-by":"crossref","first-page":"74209","DOI":"10.18632\/oncotarget.18474","article-title":"The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clinre.2022.102003_bib0072","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the J apanese using multiple genetic markers","volume":"13","author":"TK","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2022.102003_bib0073","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2022.102003_bib0074","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2022.102003_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101710","article-title":"Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target","volume":"45","author":"Colak","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinre.2022.102003_bib0076","doi-asserted-by":"crossref","first-page":"e3575","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of gut microbiota and PNPLA3 rs738409 variant on nonalcoholic fatty liver disease (NAFLD) in Obese Youth","volume":"105","author":"Monga-Kravetz","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinre.2022.102003_bib0077","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiu002","article-title":"Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease","volume":"91","author":"Michail","year":"2015","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.clinre.2022.102003_bib0078","article-title":"The influence of Host Genetics on liver microbiome composition in patients with NAFLD","volume":"76","author":"Pirola","year":"2022","journal-title":"eBioMedicines"},{"issue":"8","key":"10.1016\/j.clinre.2022.102003_bib0079","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/msb.20177703","article-title":"Network analyses identify liver-specific targets for treating liver diseases","volume":"13","author":"Lee","year":"2017","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.clinre.2022.102003_bib0080","first-page":"16","article-title":"Analysis of protein interactions using gene coexpression networks","volume":"8","author":"Shen","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clinre.2022.102003_bib0081","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M k nock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.clinre.2022.102003_bib0082","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2022.102003_bib0083","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"PNPLA3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2022.102003_bib0084","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2020.01.053","article-title":"Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond","volume":"158","author":"Krawczyk","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:36Z","timestamp":1761896076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740122001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2210740122001371"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2022.102003","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAFLD: genetics and its clinical implications","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2022.102003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102003"}}